These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15971430)

  • 1. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.
    Pisoni CN; Obermoser G; Cuadrado MJ; Sanchez FJ; Karim Y; Sepp NT; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 2005; 23(3):393-6. PubMed ID: 15971430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
    Schanz S; Ulmer A; Rassner G; Fierlbeck G
    Br J Dermatol; 2002 Jul; 147(1):174-8. PubMed ID: 12100205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C; Vollenhoven Rv
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
    Mok CC
    Scand J Rheumatol; 2007; 36(5):329-37. PubMed ID: 17963161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN; Sanchez FJ; Karim Y; Cuadrado MJ; D'Cruz DP; Abbs IC; Khamasta MA; Hughes GR
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM; Somers EC; Fatica RA; McCune WJ
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C; Crowson CS; Matteson EL; Moder KG
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Chang HK
    J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M; Sheinberg P; Sidi Y; Schiffenbauer Y; Trubniykov E; Shoenfeld Y
    Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
    Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH
    Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R; Miyazawa H; Nishimura K; Momoi T; Nozawa T; Kikuchi M; Sakurai N; Kizawa T; Shimamura S; Yasuda S; Hiromura K; Sada KE; Kawaguchi Y; Tamura N; Takei S; Takasaki Y; Atsumi T; Mori M
    Mod Rheumatol; 2015; 25(6):858-64. PubMed ID: 26215483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Suzuki D; Ogawa N; Sawada J; Kimoto O; Shimoyama K; Hayashi H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry.
    Jung UH; Kwak SG; Choe JY; Lee SS; Kim SK
    J Korean Med Sci; 2019 Jul; 34(27):e185. PubMed ID: 31293110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.